Skip to main content

Overview

Luke Kim, M.D. received his undergraduate degree from Johns Hopkins University and his M.D. degree from Duke University School of Medicine. He completed his internship, residency in Internal Medicine, fellowship in Clinical and Interventional Cardiology at NYPH-Cornell Campus. He also completed an advanced training in structural and peripheral vascular fellowship at Hahnemann University hospital.


Dr. Kim's research interests includes the evaluation of antiplatelet therapy in acute coronary syndromes and assessment of clinical outcomes of patients with peripheral vascular disease.


From a clinical standpoint, Dr. Kim specializes in percutaneous interventions of coronary arteries as well as endovascular treatment of peripheral vascular disease. Endovascular therapy for carotid disease is improving rapidly, and Dr. Kim has extensive training in this area utilizing cutting-edge technology. In addition, Dr. Kim provides outpatient services for patients with a history of carotid artery disease.

Highlights

  1. 1
    Journal of the American Heart Association · 2024
    PMID: 38240236PMCID: PMC11056174DOISenior author35 citations
  2. 2
    European journal of heart failure · 2021
    PMID: 34114302DOISenior author53 citations
  3. 3
    Journal of the Society for Cardiovascular Angiography & Interventions · 2022
    PMID: 39131452PMCID: PMC11308692DOISenior author18 citations

Publications

119 publications

Funding

4 grants
Completed grants (4)
  • PI
    Outcomes of Advances in Therapy in Aortic Stenosis
    Michael Wolk Heart Foundation, Inc. · 2017–2020
    MWHFI 17081089-02
  • PI
    Outcomes of Advances in Therapy in Aortic Stenosis
    New York Cardiac Center, Inc. · 2017–2019
    NYCC 17081250-02
  • PI
    Rates of Coronary Artery Revascularization and Outcomes After Percutaneous Coronary Interventions and Coronary Artery Bypass
    Michael Wolk Heart Foundation, Inc. · 2015–2017
    MWHFI 15071078-02 EWOF
  • PI
    Rates of Coronary Artery Revascularization and Outcomes After Percutaneous Coronary Interventions and Coronary Artery Bypass
    New York Cardiac Center, Inc. · 2015–2017
    NYCCI 15071021-02 EWOF